PATENT CLAIM ANALYSIS

Application Number: 16028235
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["424", "130100"]

Abstract:
The present invention relates to methods and medicaments useful for treating idiopathic pulmonary fibrosis (IPF) by administering anti-CTGF antibodies. Methods for prognosing individuals with IPF are also provided.

Claim (Index 2):
The method of  claim 1 , wherein treating IPF comprises reducing the pathologic rate of decline of a pulmonary function parameter by at least 5%.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 95.0
- Lexical Diversity: 1.10345
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14398380', '15263767', '12460376', '13374308', '14741747']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7875838906980419
- 35 USC 102 Novelty (BERT): 0.5994437828683865
- Combined Prediction Score: 0.7687698799150764
- Mean Citation Score: 502.49907800000005
- Max Citation Score: 743.4912
- Similarity Product: 416.18304088954926

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test